Impact of a Pharmacist-Driven Protocol to Improve Guideline-Concordant Prescribing of Diabetes Medications in Patients With Atherosclerotic Cardiovascular Disease: A Pilot Study.

Dakota L Freudenberg Les P CovingtonRodney B YoungNicole D LopezMiti V PatelEric J MacLaughlin

Published in: Journal of pharmacy practice (2020)

Implementation of a pharmacist-driven protocol can increase guideline-concordant prescribing. However, further exploration of patient- and system-level barriers is necessary to implement such a program more broadly.

Keyphrases

cardiovascular disease
primary care
randomized controlled trial
quality improvement
type diabetes
healthcare
case report
adverse drug
glycemic control
cardiovascular risk factors
metabolic syndrome
skeletal muscle
coronary artery disease
insulin resistance
weight loss